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(encompassing such journals as New England Jour-
nal of Medicine, The Lancet, JAMA, or BMJ). A jour‑
nal’s quartile ranking is determined by comparing 
a journal to others in its Journal Citation Reports 
category, sourced from the Web of Science Core 
Collection, based on the IF score. If a journal falls 
in the Q1 category, it means that it performs bet‑
ter than at least 75% of journals in that category.
This is a tremendous honor for our journal, 
and this success would not have been achieved 
without our authors and hard work of the re‑
viewers, Editorial Board, and editorial staff. 
As it usually happens at this time of the year, we 
are looking at new journal impact factors (IFs) of 
Polish biomedical journals. This year we are hap‑
py to announce that the 2017 IF for Pol Arch In-
tern Med is 2.658, and it has increased by 15% as 
compared with the previous year (TABLE 1). We are 
proud of this excellent result, as the 2017 IFs of 
the other journals increased on average by 10%. 
Moreover, we have been ranked by Clarivate Ana‑
lytics (formerly Thomson Reuters) in the highest 
Journal Impact Factor Quartile (Q1) in the cat‑
egory of “Medicine, General & Internal” journals 
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TABLE 1 Impact factors of Polish biomedical journals (based on 2017 Journal Citation Reports, Clarivate Analytics)
Journal Impact factor 2017 Impact factor 2016
Archivum Immunologiae et Therapiae Experimentalis ↑ 3.018 2.040
Pharmacological Reports ↑2.787 2.686
Polish Archives of Internal Medicine ↑ 2.658 2.309
Journal of Physiology and Pharmacology ↓ 2.478 2.883
Archives of Medical Science ↑ 2.344 1.969
Journal of Contemporary Brachytherapy ↑ 2.146 1.496
Advances in Medical Sciences ↑ 2.064 1.364
Hereditary Cancer in Clinical Practice ↑ 2.027 1.590
Central European Journal of Immunology ↑ 1.787 0.776
Journal of Applied Genetics ↑ 1.756 1.655
Postępy Dermatologii i Alergologii ↓ 1.471 1.683
Postępy w Kardiologii Interwencyjnej ↑ 1.443 0.917
Folia Neuropathologica ↑ 1.345 1.093
Cardiology Journal ↑ 1.339 1.256
Advances in Clinical and Experimental Medicine ↑ 1.262 1.179
Kardiologia Polska ↓ 1.227 1.341
Endokrynologia Polska ↓ 1.059 1.341
Polish Journal of Pathology ↓ 0.865 0.990
Neurologia i Neurochirurgia Polska ↓ 0.817 0.857
Postępy Higieny i Medycyny Doświadczalnej ↑ 0.783 0.690
Ginekologia Polska ↑ 0.621 0.576
Folia Morphologica ↑ 0.497 0.341
Open Medicine ↑ 0.484 0.294
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the years 2015–2016 that were most highly cit‑
ed in 2017 are listed in TABLE 2. We consider this 
a good sign that all of the most cited original pa‑
pers were submitted by Polish researchers and 
that their quality helped us improve our standing 
among medical journals. Moreover, it is the orig‑
inal papers that contributed most to this year’s 
IF, which is a continuous trend in Pol Arch Intern 
Med. We believe that the journal has a strong po‑
tential for becoming an internationally recog‑
nized and an influential periodical, and again we 
would like to thank all authors who submitted 
their manuscripts to us.
Currently, the manuscript acceptance rate is 
37%. Some papers are still rejected without peer 
review, which is an increasingly common poli‑
cy among journals. It is guided by the fact that 
many submitted papers do not fit into the the‑
matic scope of the journal or editors have con‑
cerns about the novelty or quality of submitted 
research. Another reason is to reduce the bur‑
den for our external reviewers. In this editori‑
al, we would like to acknowledge their excel‑
lent work. Without their commitment and crit‑
ical attitude, it would not be possible to select 
the best papers for publication. The most active 
Although the current IF gives us a strong posi‑
tion nationally and even internationally, we are 
aware of the shortcomings of the IF as a mea‑
sure of the journal’s impact. Clarivate Analytics 
calculates it annually by dividing the number of 
current ‑year citations to source items published 
in that journal during the previous 2 years. The IF, 
however simplified and imperfect, currently ex‑
ists as the main measure for assessing the quali‑
ty and importance of medical journals. The main 
disadvantage of such a system is that journals 
may favor the papers because they will be high‑
ly cited and could affect their IF. In Pol Arch In-
tern Med, we avoid accepting manuscripts just 
for their “citability” and significance for the IF 
score. Rather, we place priority on the novelty 
and sound methodology of research. We also fa‑
vor papers that may be important for readers, 
can influence clinical practice, and have a transla‑
tional value. Finally, our experience over the last 
years shows that it is quite difficult to predict how 
the papers will be cited.
Several original and review papers, cover‑
ing diverse topics in the field of internal med‑
icine, had a major contribution to the 2017 IF 
of Pol Arch Intern Med. The articles published in 
TABLE 2 Most cited original and review papers contributing to IF 2017 (based on Web of Science Core Collection, Clarivate Analytics; June 17, 2018)
No. Paper Citation count in 2017  
(total citation count)
1 Kasińska MA, Drzewoski J. Effectiveness of probiotics in type 2 diabetes: a meta ‑analysis. Pol Arch Med 
Wewn. 2015; 125: 803‑813.
10 (18)
2 Gąsior M, Pres D, Wojakowski W, et al. Causes of hospitalization and prognosis in patients with 
cardiovascular diseases: secular trends in the years 2006–2014 according to the SILesian CARDiovascular 
(SILCARD) database. Pol Arch Med Wewn. 2016; 126: 754‑762.
9 (13)
3 Świerkot J, Ślęzak R, Karpiński P, et al. Associations between single ‑nucleotide polymorphisms of RFC ‑1, 
GGH, MTHFR, TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients 
with rheumatoid arthritis. Pol Arch Med Wewn. 2015; 125: 152‑161.
8 (16)
4 Prejbisz A, Klocek M, Gąsowski J, et al. Factors associated with resistant hypertension in a large cohort of 
hypertensive patients: the Pol ‑Fokus study. Pol Arch Med Wewn. 2015; 125: 249‑259.
8 (11)
5 Golicki D, Niewada M. General population reference values for 3 ‑level EQ ‑5D (EQ ‑5D ‑3L) questionnaire in 
Poland. Pol Arch Med Wewn. 2015; 125: 18‑26.
7 (18)
6 Florczak E, Tokarczyk B, Warchoł ‑Celińska E, et al. Assessment of adherence to treatment in patients with 
resistant hypertension using toxicological serum analysis: a subgroup evaluation of the RESIST -POL study. 
Pol Arch Med Wewn. 2015; 125: 65‑72.
7 (15)
7 Hart RG, Ng KH. Stroke prevention in asymptomatic carotid artery disease: revascularization of carotid 
stenosis is not the solution. Pol Arch Med Wewn. 2015; 125: 363‑369.
7 (9)
8 Kurnatowska I, Grzelak P, Masajtis ‑Zagajewska A, et al. Effect of vitamin K2 on progression of 
atherosclerosis and vascular calcification in nondialyzed patients with chronic kidney disease stages 3–5. 
Pol Arch Med Wewn. 2015; 125: 631‑640.
6 (18)
9 Płudowski P, Ducki C, Konstantynowicz J, Jaworski M. Vitamin D status in Poland. Pol Arch Med Wewn. 
2016; 126: 530-539.
6 (13)
10 Pengo V, Denas G, Padayattil SJ, et al. Diagnosis and therapy of antiphospholipid syndrome. Pol Arch Med 
Wewn. 2015; 125: 672‑677.
6 (13)
11 Krasińska B, Miazga A, Cofta S, et al. Effect of eplerenone on the severity of obstructive sleep apnea and 
arterial stiffness in patients with resistant arterial hypertension. Pol Arch Med Wewn. 2016; 126: 330‑339.
6 (11)
12 Kapłon ‑Cieślicka A, Ozierański K, Balsam P, et al. Clinical characteristics and 1 -year outcome of 
hyponatremic patients hospitalized for heart failure. Pol Arch Med Wewn. 2015; 125: 120‑131.
6 (10)
13 Kałużna M, Hoppe K, Schwermer K, et al. Adropin and irisin levels in relation to nutrition, body composition, 
and insulin resistance in patients with end ‑stage renal disease on chronic hemodialysis and peritoneal 
dialysis. Pol Arch Med Wewn. 2016; 126: 474‑482.
6 (8)
14 Rusak M, Eljaszewicz A, Bolkun Ł, et al. Prognostic significance of PD -1 expression on peripheral blood 
CD4+T cells in patients with newly diagnosed chronic lymphocytic leukemia. Pol Arch Med Wewn. 2015; 
125: 553-559.
6 (7)
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reviewers in 2017 are listed in TABLE 3. The list of 
all reviewers who contributed a review in 2017 
can be found on the journal’s website.
We sincerely invite all authors to submit their 
high ‑quality research to our journal, both in the 
format of original papers and research letters. The 
latter is dedicated especially for reporting prelim‑
inary and focused results of original investiga‑
tions that deserve rapid publication. Despite the 
increasing volume of submissions, we still guar‑
antee quick editorial processing times: from sub‑
mission to the first decision, 2 days; from submis‑
sion to first reviews, 25 days; and from acceptance 
to online publication, 16 days. This would not be 
possible without the hard work of our Managing 
Editors: formerly Weronika Kużdżał and current‑
ly Maria Piasecka, PhD.
We also encourage all authors to cite any rel‑
evant papers published in Pol Arch Intern Med in 
their works. We are very grateful to the authors 
whose citations contributed significantly to our 
IF (TABLE 4).
We would like to announce that as of August 1, 
2018, Professor Grzegorz Gajos, former Vice 
Editor ‑in ‑Chief, is the Executive Editor of Pol 
Arch Intern Med. He is responsible for the edi‑
torial processes, working in close collaboration 
with the Editorial Board, including Professor An‑
etta Undas.
OPEN ACCESS This is an Open Access article dis‑
tributed under the terms of the Creative Com‑
mons Attribution ‑NonCommercial ‑ShareAlike 
4.0 International License (CC BY ‑NC ‑SA 4.0), 
allowing third parties to copy and redistribute 
the material in any medium or format and to re‑
mix, transform, and build upon the material, pro‑
vided the original work is properly cited, distrib‑
uted under the same license, and used for non‑
commercial purposes only. For commercial use, 
please contact the journal office at pamw@mp.pl.







TABLE 4 Authors with greatest contribution to 
the 2017 journal impact factor (based on Web of 
Science Core Collection)
Anetta Undas
Krzysztof J. Filipiak
Mariusz Gąsior
Artur Dziewierz
Andrzej Januszewicz
Piotr Podolec
